Sanis Health Inc. — licence 101796, currently licensed, last inspection rating I (2024-07-23).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02406373 | APO-MOXIFLOXACIN | APOTEX INC | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Marketed |
| 02517108 | APO-MOXIFLOXACIN HYDROCHLORIDE | APOTEX INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Approved |
| 02432242 | AURO-MOXIFLOXACIN | AURO PHARMA INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Marketed |
| 02446197 | IPG-MOXIFLOXACIN | MARCAN PHARMACEUTICALS INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Approved |
| 02443929 | JAMP-MOXIFLOXACIN | JAMP PHARMA CORPORATION | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Marketed |
| 02472791 | M-MOXIFLOXACIN | MANTRA PHARMA INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Marketed |
| 02457814 | MED-MOXIFLOXACIN | GENERIC MEDICAL PARTNERS INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Approved |
| 02462974 | MOXIFLOXACIN | PRO DOC LIMITEE | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Marketed |
| 02529076 | MOXIFLOXACIN | SANIS HEALTH INC | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Marketed |
| 02562197 | MOXIFLOXACIN INJECTION | HIKMA CANADA LIMITED | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Approved |
| 02433087 | MOXIFLOXACIN INJECTION | FRESENIUS KABI CANADA LTD | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Marketed |
| 02485702 | MOXIFLOXACIN OPHTHALMIC SOLUTION | BEXIMCO PHARMACEUTICALS CANADA LIMITED | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Approved |
| 02432218 | PMS-MOXIFLOXACIN | PHARMASCIENCE INC | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Marketed |
| 02383381 | SANDOZ MOXIFLOXACIN | SANDOZ CANADA INCORPORATED | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Marketed |
| 02411520 | SANDOZ MOXIFLOXACIN | SANDOZ CANADA INCORPORATED | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Marketed |
| 02375702 | TEVA-MOXIFLOXACIN | TEVA CANADA LIMITED | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Marketed |
| 02420511 | TEVA-MOXIFLOXACIN | TEVA CANADA LIMITED | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Approved |
| 02252260 | VIGAMOX | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Marketed |
| 02404656 | ACT MOXIFLOXACIN | TEVA CANADA LIMITED | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Cancelled Post Market |
| 02484757 | AG-MOXIFLOXACIN | ANGITA PHARMA INC. | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Dormant |
| 02478137 | AG-MOXIFLOXACIN | ANGITA PHARMA INC. | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Dormant |
| 02404923 | APO-MOXIFLOXACIN | APOTEX INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Dormant |
| 02242965 | AVELOX | BAYER INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Post Market |
| 02246414 | AVELOX I.V. | BAYER INC | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Post Market |
| 02447266 | BIO-MOXIFLOXACIN | BIOMED PHARMA | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Post Market |
| 02307154 | DOM-MOXIFLOXACIN | DOMINION PHARMACAL | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Pre Market |
| 02472120 | JAMP-MOXIFLOXACIN | JAMP PHARMA CORPORATION | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Dormant |
| 02447061 | JAMP-MOXIFLOXACIN TABLETS | JAMP PHARMA CORPORATION | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Dormant |
| 02447053 | MAR-MOXIFLOXACIN | MARCAN PHARMACEUTICALS INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Post Market |
| 02406136 | MYLAN-MOXIFLOXACIN | MYLAN PHARMACEUTICALS ULC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Pre Market |
| 02429578 | MYLAN-MOXIFLOXACIN HCL OPHTHALMIC SOLUTION | MYLAN PHARMACEUTICALS ULC | Solution | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 0.5 % | Cancelled Pre Market |
| 02307162 | PHL-MOXIFLOXACIN | PHARMEL INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Pre Market |
| 02304821 | PMS-MOXIFLOXACIN | PHARMASCIENCE INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Pre Market |
| 02447371 | PRIVA-MOXIFLOXACIN | PHARMAPAR INC | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Post Market |
| 02450976 | RIVA-MOXIFLOXACIN | LABORATOIRE RIVA INC. | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled Post Market |
| 02445174 | TORRENT-MOXIFLOXACIN | TORRENT PHARMACEUTICALS LIMITED | Tablet | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400 MG | Cancelled (Unreturned Annual) |